Clinical Evaluation of Shengdi Dahuang Decoction in the Treatment of Acute Hemorrhagic Stroke

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 464 participants.

Also called NCT04200781

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 464 participants (planned count) (from the registry)
Sponsor
ShuGuang Hospital (from the registry)
Registry
  • NCT NCT04200781
Other papers using this trial's data
  • Treatment of acute intracerebral haemorrhage with a Chinese herbal formula (Shengdi Dahuang Decoction): a multicentre, double-blind, randomised, placebo-controlled trial Stroke and vascular neurology, 2026-04-27 DOI, PubMed 40752894, PMC13151873 In the PMC Open Access subset under CC BY-NC.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04200781. Randomized; double masking; primary purpose treatment. Start 2019-09-01 (actual); primary completion 2022-06-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Clinical Evaluation of Shengdi Dahuang Decoction in the Treatment of Acute Hemorrhagic Stroke
Condition
Hemorrhagic Stroke
Intervention (Drug)
Granules of Shengdi Dahuang Decoction
Intervention (Drug)
Placebo
Lead sponsor
ShuGuang Hospital (class: other)

Record details

Record id
cardio:ct-nct04200781
Content hash
457b82583c61c5442b296fb43e384198f2633ced0d205c02ca99c3b54886c09f